Skip to main content
×
Home
    • Aa
    • Aa

Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis

  • Le Ma (a1), Hong-Liang Dou (a2), Yi-Qun Wu (a3), Yang-Mu Huang (a1), Yu-Bei Huang (a3), Xian-Rong Xu (a1), Zhi-Yong Zou (a1) and Xiao-Ming Lin (a1)...
Abstract

Lutein and zeaxanthin are thought to decrease the incidence of age-related macular degeneration (AMD); however, findings have been inconsistent. We conducted a systematic literature review and meta-analysis to evaluate the relationship between dietary intake of lutein and zeaxanthin and AMD risk. Relevant studies were identified by searching five databases up to April 2010. Reference lists of articles were retrieved, and experts were contacted. Literature search, data extraction and study quality assessment were performed independently by two reviewers and results were pooled quantitatively using meta-analysis methods. The potential sources of heterogeneity and publication bias were also estimated. The search yielded six longitudinal cohort studies. The pooled relative risk (RR) for early AMD, comparing the highest with the lowest category of lutein and zeaxanthin intake, was 0·96 (95 % CI 0·78, 1·17). Dietary intake of these carotenoids was significantly related with a reduction in risk of late AMD (RR 0·74; 95 % CI 0·57, 0·97); and a statistically significant inverse association was observed between lutein and zeaxanthin intake and neovascular AMD risk (RR 0·68; 95 % CI 0·51, 0·92). The results were essentially consistent among subgroups stratified by participant characteristics. The findings of the present meta-analysis indicate that dietary lutein and zeaxanthin is not significantly associated with a reduced risk of early AMD, whereas an increase in the intake of these carotenoids may be protective against late AMD. However, additional studies are needed to confirm these relationships.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis
      Available formats
      ×
Copyright
Corresponding author
*Corresponding author: X.-M. Lin, fax +86 10 62015583, email linbjmu@bjmu.edu.cn
References
Hide All
1 Jager RD, Mieler WF & Miller JW (2008) Age-related macular degeneration. N Engl J Med 358, 26062617.
2 Muni RH, Altaweel M, Tennant M, et al. (2008) Agreement among Canadian retina specialists in the determination of treatment eligibility for photodynamic therapy in age-related macular degeneration. Retina 28, 14211426.
3 Klein R, Peto T, Bird A, et al. (2004) The epidemiology of age-related macular degeneration. Am J Ophthalmol 137, 486495.
4 Evans JR, Fletcher AE & Wormald RPL (2004) Age-related macular degeneration causing visual impairment in people 75 years or older in Britain: an add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community. Ophthalmology 111, 513517.
5 Friedman DS, O'Colmain BJ, Muñoz B, et al. (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122, 564572.
6 Khan JC, Shahid H, Thurlby DA, et al. (2006) Age-related macular degeneration and sun exposure, iris colour, and skin sensitivity to sunlight. Br J Ophthalmol 90, 2932.
7 Klein RJ, Zeiss C, Chew EY, et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308, 385389.
8 Schmidt S, Haines JL, Postel EA, et al. (2005) Joint effects of smoking history and APOE genotypes in age-related macular degeneration. Mol Vis 11, 941949.
9 Subramanian ML, Ness S, Abedi G, et al. (2009) Bevacizumab vs ranibizumab for age-related macular degeneration: early results of a prospective double-masked, randomized clinical trial. Am J Ophthalmol 148, 875882.
10 Thornton J, Edwards R, Mitchell P, et al. (2005) Smoking and age-related macular degeneration: a review of association. Eye 19, 935944.
11 Dillon J, Zhenga L, Merriama JC, et al. (2004) Transmission of light to the aging human retina: possible implications for age-related macular degeneration. Exp Eye Res 79, 753759.
12 Smith W, Assink J, Klein R, et al. (2001) Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 108, 697704.
13 Kowluru RA, Menon B & Gierhart D (2008) Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rat. Invest Ophthalmol Vis Sci 49, 16451651.
14 Cai J, Nelson K, Wu M, et al. (2000) Oxidative damage and protection of RPE. Prog Retin Eye Res 19, 205221.
15 Izumi-Nagai K, Nagai N, Ohgami K, et al. (2007) Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization. Arterioscler Thromb Vasc Biol 27, 25552562.
16 Margrain TH, Boulton M, Marshall J, et al. (2004) Do blue light filters confer protection against age-related macular degeneration? Prog Ret Eye Res 23, 523531.
17 Krishnadev N, Meleth AD & Chew EY (2010) Nutritional supplements for age-related macular degeneration. Curr Opin Ophthalmol 21, 184189.
18 Haegele AD, Gillette C, O'Neill C, et al. (2000) Plasma xanthophyll carotenoids correlate inversely with indices of oxidative DNA damage and lipid peroxidation. Cancer Epidemiol Biomark Prev 9, 421425.
19 Thomson LR, Toyoda Y, Langner A, et al. (2002) Elevated retinal zeaxanthin and prevention of light-induced photoreceptor cell death in quail. Invest Ophthalmol Vis Sci 43, 35383549.
20 Junghans A, Sies H & Stahl W (2001) Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes. Arch Biochem Biophys 391, 160164.
21 Flood V, Smith W, Wang JJ, et al. (2002) Dietary antioxidant intake and incidence of early age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology 109, 22722278.
22 Cho E, Seddon JM, Rosner B, et al. (2004) Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol 122, 883892.
23 van Leeuwen R, Boekhoorn S, Vingerling JR, et al. (2005) Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA 294, 31013107.
24 Tan JS, Wang JJ, Flood V, et al. (2008) Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 115, 334341.
25 Wells G, Shea B & O'Connell D, et al. (2010) The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm (accessed January 2010).
26 Higgins JP, Thompson SG, Deeks JJ, et al. (2003) Measuring inconsistency in meta-analyses. BMJ 327, 557560.
27 Egger M, Davey Smith G, Schneider M, et al. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629634.
28 Sterne JA & Egger M (2001) Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 54, 10461055.
29 Van den Langenberg GM, Mares PJ, Klein R, et al. (1998) Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol 148, 204214.
30 Moeller S, Parekh N, Tinker L, et al. (2006) Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative. Arch Ophthalmol 124, 11511162.
31 Cho E, Hankinson SE, Rosner B, et al. (2008) Prospective study of lutein/zeaxanthin intake and risk of age-related macular degeneration. Am J Clin Nutr 87, 18371843.
32 Khachik F, Bernstein PS & Garland DL (1997) Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest Ophthalmol Vis Sci 38, 18021811.
33 Ma L & Lin XM (2010) Effects of lutein and zeaxanthin on aspects of eye health. J Sci Food Agric 90, 212.
34 Rapp LM, Maple SS & Choi JH (2000) Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina. Invest Ophthalmol Vis Sci 41, 12001209.
35 Stahl W & Sies H (1993) Physical quenching of singlet oxygen and cistrans isomerization of carotenoids. Ann NY Acad Sci 691, 1019.
36 Krinsky NI, Landrum JT & Bone RA (2003) Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr 23, 171201.
37 Thomson LR, Toyoda Y, Delori FC, et al. (2002) Long term dietary supplementation with zeaxanthin reduces photoreceptor death in light-damaged Japanese quail. Exp Eye Res 75, 529542.
38 Donoso LA, Kim D, Frost A, et al. (2006) The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 51, 137152.
39 Seddon JM, Gensler G, Milton RC, et al. (2004) Association between C-reactive protein and age-related macular degeneration. JAMA 291, 704710.
40 Kowluru RA, Menon B & Gierhart D (2008) Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rat. Invest Ophthalmol Vis Sci 49, 16451651.
41 Seddon J, Anani A, Sperduto R, et al. (1994) Dietary carotenoids, vitamin A, C, E and advanced age-related macular degeneration. Eye Disease Case Controlled Study Group. JAMA 272, 14131420.
42 AREDS Research Group (2007) The relationship of dietary carotenoid and vitamin A, E and C intake with age-related macular degeneration in a case–control study. AREDS report no. 22. Arch Ophthalmol 125, 12251232.
43 Mares-Perlman JA, Fisher AI, Klein R, et al. (2001) Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 153, 424432.
44 Chiu CJ, Milton RC, Klein R, et al. (2009) Dietary compound score and risk of age-related macular degeneration in the Age-related Eye Disease Study. Ophthalmology 116, 939946.
45 Bone RA, Landrum JT, Dixon Z, et al. (2000) Lutein and zeaxanthin in the eyes, serum and diet of human subjects. Exp Eye Res 71, 239245.
46 Zhang X, Shu XO, Chow WH, et al. (2008) Body mass index at various ages and mortality in Chinese women: impact of potential methodological biases. Int J Obes 32, 11301136.
47 Berendschot TT, Willemse-Assink JJ, Bastiaanse M, et al. (2002) Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci 43, 19281932.
48 Jahn C, Wustemeyer H, Brinkmann C, et al. (2005) Macular pigment density in age-related maculopathy. Graefes Arch Clin Exp Ophthalmol 243, 222227.
49 Beatty S, Murray IJ, Henson DB, et al. (2001) Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 42, 439446.
50 Wüstemeyer H, Jahn C, Nestler A, et al. (2002) A new instrument for the quantification of macular pigment density: first results in patients with AMD and healthy subjects. Graefes Arch Clin Exp Ophthalmol 240, 666671.
51 Bone R, Landrum J, Mayne S, et al. (2001) Macular pigment in donor eyes with and without AMD: a case–controlled study. Invest Ophthalmol Vis Sci 42, 235240.
52 Choi JS, Kim D, Hong Y, et al. (2006) Inhibition of nNOS and COX-2 expression by lutein in acute retinal ischemia. Nutrition 22, 668671.
53 Freeman WR, El-Bradey M & Plummer DJ (2004) Scanning laser entoptic perimetry for the detection of age-related macular degeneration. Arch Ophthalmol 122, 16471651.
54 Van den Langenberg GM, Brady WE, Nebeling LC, et al. (1996) Influence of using different sources of carotenoid data in epidemiologic studies. J Am Diet Assoc 96, 12711275.
55 Seddon J, George S & Rosner B (2006) Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration. The US twin study of age-related macular degeneration. Arch Ophthalmol 124, 9951001.
56 Seddon JM, Cote J, Page WF, et al. (2005) The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 123, 321327.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 68
Total number of PDF views: 442 *
Loading metrics...

Abstract views

Total abstract views: 1078 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 21st October 2017. This data will be updated every 24 hours.